Transcriptome free energy can serve as a dynamic patient-specific biomarker in acute myeloid leukemia

Transcriptome free energy can serve as a dynamic patient-specific biomarker in acute myeloid leukemia

Abstract Acute myeloid leukemia (AML) is prevalent in both adult and pediatric patients. Despite advances in patient categorization, the heterogeneity of AML remains a challenge. Recent studies have explored the use of gene expression data to enhance AML diagnosis and prognosis, however, alternative...

Full description

Bibliographic Details
Main Authors: Lisa Uechi, Swetha Vasudevan, Daniela Vilenski, Sergio Branciamore, David Frankhouser, Denis O’Meally, Soheil Meshinchi, Guido Marcucci, Ya-Huei Kuo, Russell Rockne, Nataly Kravchenko-Balasha
Format: Article
Language:English
Published: Nature Portfolio 2024-03-01
Series:npj Systems Biology and Applications
Online Access:https://doi.org/10.1038/s41540-024-00352-6

Internet

https://doi.org/10.1038/s41540-024-00352-6

Similar Items